Anyone can get colorectal cancer. Doctors often don't know why it happens, but they know some of the things that make people more likely to get it. These include: Age. The disease is most common ...
About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.